Thema
Journal Article
284
Review
76
Research Support, Non-U.S. Gov't
54
Anti-Bacterial Agents
48
NSCLC
36
COVID-19
34
EC 2.7.10.1
27
Comment
24
Immunotherapy
23
Multicenter Study
21
Biomarkers, Tumor
19
Observational Study
19
Letter
18
Pneumonia
17
Case Reports
15
Daptomycin
15
Biomarkers
14
ErbB Receptors
14
Protein Kinase Inhibitors
14
SARS-CoV-2
14
Non-small cell lung cancer
13
B7-H1 Antigen
12
Comparative Study
12
Systematic Review
12
Immune Checkpoint Inhibitors
11
Liquid biopsy
10
PD-L1
10
EGFR protein, human
9
615
8
A61L: Methods or apparatus for sterilising materials or objects in general; disinfection, sterilisation, or deodorisation of air; chemical aspects of bandages, dressings, absorbent pads, or surgical articles; materials for bandages, dressings, absorbent pads, or surgical articles (preservation of bodies or disinfecting characterised by the agent employed a01n;preserving, e.g. sterilising, food or foodstuffs a23;preparations for medical, dental or toilet purposes a61k)
8
A61M: Devices for introducing media into, or onto, the body (introducing media into or onto the bodies of animals a61d0007000000; means for inserting tampons a61f0013260000; devices for administering food or medicines orally a61j; containers for collecting, storing or administering blood or medical fluids a61j0001050000); devices for transducing body media or for taking media from the body (surgery a61b; chemical aspects of surgical articles a61l; magnetotherapy using magnetic elements placed within the body a61n0002100000); devices for producing or ending sleep or stupor
8
A61N: Electrotherapy; magnetotherapy; radiation therapy; ultrasound therapy (measurement of bioelectric currents a61b;surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body a61b0018000000;anaesthetic apparatus in general a61m;incandescent lamps h01k;infra-red radiators for heating h05b)
8
B82Y: Specific uses or applications of nanostructures; measurement or analysis of nanostructures; manufacture or treatment of nanostructures
8
Editorial
8
Immune checkpoint inhibitors
8
NWQ5N31VKK
8
Nivolumab
8
Septic shock
8
Medium
8
phy
8
septic shock
8
Aspirin
7
Bacteremia
7
Biomaterials
7
EGFR
7
Lung cancer
7
Pembrolizumab
7
Terlipressin
7
lung cancer
7
Antineoplastic Agents, Immunological
6
mehr ...